DarioHealth Statistics

Total Valuation

DarioHealth has a market cap or net worth of $54.02 million. The enterprise value is $59.75 million.

Market Cap	54.02M
Enterprise Value	59.75M

Important Dates

The next estimated earnings date is Thursday, May 14, 2026, before market open.

Earnings Date	May 14, 2026
Ex-Dividend Date	n/a

Share Statistics

DarioHealth has 7.30 million shares outstanding. The number of shares has increased by 62.44% in one year.

Current Share Class	7.30M
Shares Outstanding	7.30M
Shares Change (YoY)	+62.44%
Shares Change (QoQ)	+152.08%
Owned by Insiders (%)	20.01%
Owned by Institutions (%)	4.96%
Float	5.26M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.42
Forward PS	2.03
PB Ratio	0.75
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2.67
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.76, with a Debt / Equity ratio of 0.47.

Current Ratio	3.76
Quick Ratio	3.08
Debt / Equity	0.47
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-12.14

Financial Efficiency

Return on equity (ROE) is -59.62% and return on invested capital (ROIC) is -22.70%.

Return on Equity (ROE)	-59.62%
Return on Assets (ROA)	-20.01%
Return on Invested Capital (ROIC)	-22.70%
Return on Capital Employed (ROCE)	-36.38%
Weighted Average Cost of Capital (WACC)	9.89%
Revenue Per Employee	$135,509
Profits Per Employee	-$244,300
Employee Count	165
Asset Turnover	0.20
Inventory Turnover	1.77

Taxes

In the past 12 months, DarioHealth has paid $105,000 in taxes.

Income Tax	105,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -53.75% in the last 52 weeks. The beta is 1.28, so DarioHealth's price volatility has been higher than the market average.

Beta (5Y)	1.28
52-Week Price Change	-53.75%
50-Day Moving Average	8.72
200-Day Moving Average	11.08
Relative Strength Index (RSI)	44.64
Average Volume (20 Days)	18,659

Short Selling Information

The latest short interest is 69,155, so 0.95% of the outstanding shares have been sold short.

Short Interest	69,155
Short Previous Month	66,009
Short % of Shares Out	0.95%
Short % of Float	1.31%
Short Ratio (days to cover)	3.70

Income Statement

In the last 12 months, DarioHealth had revenue of $22.36 million and -$40.31 million in losses. Loss per share was -$10.12.

Revenue	22.36M
Gross Profit	14.34M
Operating Income	-36.66M
Pretax Income	-41.61M
Net Income	-40.31M
EBITDA	-33.52M
EBIT	-36.66M
Loss Per Share	-$10.12

Full Income Statement

Balance Sheet

The company has $26.02 million in cash and $31.75 million in debt, giving a net cash position of -$5.73 million or -$0.79 per share.

Cash & Cash Equivalents	26.02M
Total Debt	31.75M
Net Cash	-5.73M
Net Cash Per Share	-$0.79
Equity (Book Value)	67.92M
Book Value Per Share	9.84
Working Capital	25.74M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$25.94 million and capital expenditures -$142,000, giving a free cash flow of -$26.08 million.

Operating Cash Flow	-25.94M
Capital Expenditures	-142,000
Depreciation & Amortization	3.14M
Net Borrowing	185,000
Free Cash Flow	-26.08M
FCF Per Share	-$3.57

Full Cash Flow Statement

Margins

Gross margin is 64.11%, with operating and profit margins of -163.94% and -186.56%.

Gross Margin	64.11%
Operating Margin	-163.94%
Pretax Margin	-186.10%
Profit Margin	-186.56%
EBITDA Margin	-149.90%
EBIT Margin	-163.94%
FCF Margin	n/a

Dividends & Yields

DarioHealth does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-62.44%
Shareholder Yield	-62.44%
Earnings Yield	-74.62%
FCF Yield	-48.28%

Analyst Forecast

The average price target for DarioHealth is $35.00, which is 372.97% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$35.00
Price Target Difference	372.97%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	35.47%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on August 28, 2025. It was a reverse split with a ratio of 1:20.

Last Split Date	Aug 28, 2025
Split Type	Reverse
Split Ratio	1:20

Scores

DarioHealth has an Altman Z-Score of -5.75 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.75
Piotroski F-Score	2